Literature DB >> 18335253

A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.

Tadeusz Porowski1, Walentyna Zoch-Zwierz, Jerzy Konstantynowicz, Katarzyna Taranta-Janusz.   

Abstract

Published data on the association between calcium oxalate (CaOx) crystallization and kidney stone disease in children are scarce. The aims of this study were to determine CaOx crystallization using the Bonn Risk Index (BRI) in children with urolithiasis in comparison to healthy controls, to evaluate the relationships between BRI and urinary parameters, such as pH, calciuria, oxaluria and citraturia, and to assess the association between BRI and the size of renal stones. We compared the BRI in 142 Caucasian children and adolescents (76 girls, 66 boys) aged 3-18 years with kidney stones and 210 healthy age- and sex-matched controls without urolithiasis. Urinary ionized calcium ([Ca2+]) was measured using a selective electrode, while the onset of spontaneous crystallization was determined using a photometer and titration with 40 mmol/L ammonium oxalate (Ox2-). The calculation of the BRI value was based on the Ca2+:Ox2- ratio. High-resolution renal ultrasonography was carried out to estimate the size of the renal stones. The BRI values were 15-fold higher in children with renal stones than in healthy children without stones. The same trend was shown by BRI/kg body weight (tenfold greater in children with renal stones than in healthy children without stones), BRI/per 1.73 m2 body surface (13-fold greater) and BRI/body mass index (23-fold greater). No association was observed between BRI and the diameter of stones. Children with kidney stones, both males and females, had an increased BRI compared with subjects without urolithiasis. High BRI suggests an association with lower urinary pH, hypercalciuria, hyperoxaluria or hypocitraturia, which are all risk factors of kidney stones. An increased BRI in children, although unrelated to renal stone size, reflects the risk of calcium oxalate crystallization and may indicate early metabolic disorders leading to urolithiasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335253     DOI: 10.1007/s00467-008-0786-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  A prospective study of recurrence rate and risk factors for recurrence after a first renal stone.

Authors:  A Trinchieri; F Ostini; R Nespoli; F Rovera; E Montanari; G Zanetti
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

2.  Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate.

Authors:  Norbert Laube; Stefan Hergarten; Albrecht Hesse
Journal:  Clin Chem Lab Med       Date:  2002-06       Impact factor: 3.694

Review 3.  Dual role of citrate in mammalian urine.

Authors:  Orson W Moe; Patricia A Preisig
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-07       Impact factor: 2.894

Review 4.  Risk formulas in calcium oxalate urolithiasis.

Authors:  H G Tiselius
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Recurrence after a single renal stone in a community practice.

Authors:  J W Sutherland; J H Parks; F L Coe
Journal:  Miner Electrolyte Metab       Date:  1985

6.  Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones.

Authors:  V Ricchiuti; D M Hartke; L Z Yang; H B Goldman; J S Elder; M I Resnick; S R Marengo
Journal:  BJU Int       Date:  2002-10       Impact factor: 5.588

7.  Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?

Authors:  Ahmet Tefekli; Tarik Esen; Orhan Ziylan; Bülent Erol; Abdullah Armagan; Haluk Ander; Mustafa Akinci
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

8.  Pediatric urolithiasis--evaluation of risk factors in 95 children.

Authors:  Ahmet Erbagci; Ayse Binnur Erbagci; Meryem Yilmaz; Faruk Yagci; Mehmet Tarakcioglu; Cihanser Yurtseven; Oya Koyluoglu; Kemal Sarica
Journal:  Scand J Urol Nephrol       Date:  2003

9.  Determination of urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL applied to a family.

Authors:  Norbert Laube; Vera Labedzke; Stefan Hergarten; Albrecht Hesse
Journal:  J Chem Inf Comput Sci       Date:  2002 May-Jun

10.  Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome.

Authors:  Kristy VanDervoort; Jonathan Wiesen; Rachel Frank; Suzanne Vento; Virginia Crosby; Manju Chandra; Howard Trachtman
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  9 in total

Review 1.  Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge.

Authors:  Christian Fisang; Ralf Anding; Stefan C Müller; Stefan Latz; Norbert Laube
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

2.  Paediatrics: A 24 h urine collection is essential in nephrolithiasis evaluation.

Authors:  Boris Chertin
Journal:  Nat Rev Urol       Date:  2014-08-19       Impact factor: 14.432

3.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

4.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

5.  Spontaneous urinary calcium oxalate crystallization in hypercalciuric children.

Authors:  Tadeusz Porowski; Jerzy Konstantynowicz; Walentyna Zoch-Zwierz; Jan Krzysztof Kirejczyk; Katarzyna Taranta-Janusz; Agata Korzeniecka-Kozerska
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

6.  Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer.

Authors:  Wolfgang Berg; Robin Bechler; Claudia Haas; Norbert Laube
Journal:  Urol Res       Date:  2009-02-10

7.  Assessment of crystallization risk formulas in pediatric calcium stone-formers.

Authors:  Przemysław Sikora; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2009-03-31       Impact factor: 3.714

8.  Evaluation of pediatric nephrolithiasis.

Authors:  Paul J Kokorowski; Katherine Hubert; Caleb P Nelson
Journal:  Indian J Urol       Date:  2010-10

Review 9.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.